Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy

NCT02577393 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Lung Neoplasms
Esophagitis
Prevention & Control
Epigallocatechin Gallate

Interventions

DRUG: EGCG
DRUG: EGCG
DRUG: mLDG

Sponsor

Shandong Cancer Hospital and Institute